Skip to main content

Table 2 In vitro maturation outcome of PCOS women with or without hCG-priming

From: Effect of hCG priming on embryonic development of immature oocytes collected from unstimulated women with polycystic ovarian syndrome

 

hCG-primed group

Non-primed group

p

No. of oocyte retrieval cycles

40

42

 

No. of oocytes retrieved

   

Total (range)

552 (1–50)

603(1–47)

 

Mean

13.80

14.35

ns

No. of oocytes matured at 32 h

   

Total (range)

306 (1–21)

255 (0–18)

 

Mean

7.65

6.07

 

Maturation rate (%)

55.43

42.29

0.000

No. of oocytes fertilized (%)

194 (63.40)

167 (65.49)

ns

No. of oocytes cleaved (%)

192 (98.97)

166 (99.10)

ns

Cycles with embryo transfer (%)

34 (85.0)

40 (95.24)

ns

No. of embryos transferred (mean)

70 (2.06)

86 (2.15)

ns

No. of clinical pregnancies

15

21

 

Clinical pregnancy rate per ORa(%)

37.50

50.00

ns

Clinical pregnancy rate per ETb(%)

44.12

52.50

ns

No. of embryos implantation (%)

23 (32.86)

28 (32.56)

ns

No. of live birth (% per OR)

9 (22.50)

13 (30.95)

ns

Singleton

5

11

 

Twins

4

2

 

No. of infants

13

15

 

No. of miscarriage (%) c

6 (40.00)

8 (38.10)

ns

Early miscarriage (<12 weeks)

3

5

 

Late miscarriage (12–28 weeks)d

3

3

 

No. of cycles with embryo freezing

19 (47.50)

13 (30.95)

ns

  1. aOR oocyte retrieval.
  2. bET embryo transfer.
  3. c Miscarriage was defined as pregnancy loss after ultrasonographic evidence of an intrauterine pregnancy.
  4. d Late miscarriage was defined as pregnancy loss between 12 and 28 weeks of gestation, which includes any termination of pregnancy after diagnosis of a congenital abnormality.